Keurig Dr Pepper Executive Plans to Sell $1.2M in Stock Amid Recent Sales

Form 144 Notice filed for Keurig Dr Pepper (KDP) indicates insider Mary Beth Denooyer's proposed sale of 36,000 shares of common stock with an aggregate market value of $1,195,560 through J.P.

Rhea-AI Filing Summary

Form 144 Notice filed for Keurig Dr Pepper (KDP) indicates insider Mary Beth Denooyer's proposed sale of 36,000 shares of common stock with an aggregate market value of $1,195,560 through J.P. Morgan Securities. The sale is scheduled for June 20, 2025, on NASDAQ.

The securities to be sold were acquired through multiple transactions:

• Two RSU vestings in March 2024 totaling 12,746 shares
• Five open market purchases between August-December 2019 totaling 23,254 shares

Recent trading history shows Denooyer has sold 60,000 shares in the past 3 months through five separate transactions between April-June 2025, generating approximately $2.05 million in gross proceeds. The average selling price across these transactions was around $34.21 per share.

Positive

• None.

Negative

• Insider Mary Beth Denooyer has consistently sold KDP shares over the past 3 months, disposing of 60,000 shares for approximately $2.05M, and is planning to sell an additional 36,000 shares worth $1.2M, indicating a pattern of significant insider selling

FAQ

How many KDP shares is the insider planning to sell according to the June 2025 Form 144?

According to the Form 144 filing, the insider plans to sell 36,000 shares of KDP common stock through J.P. Morgan Securities LLC, with an aggregate market value of $1,195,560.

Who is the KDP insider selling shares and what is their recent trading history?

Mary Beth Denooyer is the insider selling KDP shares. Over the past 3 months (April-June 2025), she has sold 60,000 shares in five separate transactions of 12,000 shares each, with gross proceeds ranging from approximately $394,981 to $427,071 per transaction.

How did the KDP insider acquire the shares being sold?

The shares were acquired through multiple transactions: RSU vestings in March 2024 (8,808 shares and 3,938 shares) and several open market purchases in 2019 (totaling 23,254 shares). The purchases were made with cash, while the RSUs were received as compensation.

What is the total market capitalization of KDP based on shares outstanding?

According to the Form 144 filing, KDP has 1,358,178,069 shares outstanding. At the approximate per-share price implied by the filing ($33.21 based on the aggregate market value divided by shares to be sold), this would indicate a market capitalization of approximately $45.1 billion.

When is the planned sale date for the KDP shares in this Form 144?

The Form 144 indicates an approximate date of sale of June 20, 2025, and the shares will be sold on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001587484
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Keurig Dr. Pepper, Inc.
SEC File Number	001-33829
Address of Issuer	53 South Avenue Burlington MASSACHUSETTS 01803
Phone	781-418-7000
Name of Person for Whose Account the Securities are To Be Sold	Mary Beth DeNooyer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	36000	1195560	1358178069	06/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/19/2019	Open Market Purchase	See Nature of Acquisition			4450	11/20/2019	Cash
Common Stock	03/12/2024	RSU Vesting	Issuer			3938	03/12/2024	Compensation
Common Stock	12/10/2019	Open Market Purchase	See Nature of Acquisition			6500	12/11/2019	Cash
Common Stock	03/03/2024	RSU Vesting	Issuer			8808	03/03/2024	Compensation
Common Stock	11/12/2019	Open Market Purchase	See Nature of Acquisition			6000	11/13/2019	Cash
Common Stock	08/13/2019	Open Market Purchase	See Nature of Acquisition			6000	08/14/2019	Cash
Common Stock	11/05/2019	Open Market Purchase	See Nature of Acquisition			304	11/06/2010	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mary Beth Denooyer C/o Keurig Dr. Pepper, Inc. 53 South Avenue Burlington MA 01803	Common Stock	04/01/2025	12000	417383
Mary Beth Denooyer C/o Keurig Dr. Pepper, Inc. 53 South Avenue Burlington MA 01803	Common Stock	04/17/2025	12000	427071
Mary Beth Denooyer C/o Keurig Dr. Pepper, Inc. 53 South Avenue Burlington MA 01803	Common Stock	05/06/2025	12000	409303
Mary Beth Denooyer C/o Keurig Dr. Pepper, Inc. 53 South Avenue Burlington MA 01803	Common Stock	05/22/2025	12000	398478
Mary Beth Denooyer C/o Keurig Dr. Pepper, Inc. 53 South Avenue Burlington MA 01803	Common Stock	06/03/2025	12000	394981

144: Remarks and Signature

Remarks
Date of Notice	06/20/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/01/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Mary Beth DeNooyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)